During the past decade, Diagnos Klaukkalan Lääkäriasema conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Diagnos Klaukkalan Lääkäriasema" are "Chronic Kidney Disease" (1 trials) and "Neuropathic Pain Associated With Diabetic Peripheral Neuropathy" (1 trials). Many other conditions were trialed in "Diagnos Klaukkalan Lääkäriasema" in a lesser frequency.

Most popular intervention types in "Diagnos Klaukkalan Lääkäriasema" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BAY1817080" (1 trials), "Placebo" (1 trials), "Placebo for BAY1817080" (1 trials), "Placebo for Pregabalin" (1 trials) and "Pregabalin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Diagnos Klaukkalan Lääkäriasema" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Diagnos Klaukkalan Lääkäriasema". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Diagnos Klaukkalan Lääkäriasema, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Diagnos Klaukkalan Lääkäriasema, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".